The Indian Journal of Pediatrics

, Volume 63, Issue 4, pp 517–521 | Cite as

Intravenous immunoglobulin for prophylaxis of nosocomial sepsis

  • Aytuğg Atici
  • Mehmet Satar
  • Aysun Karabay
  • Mustafa Yilmaz
Original Article

Abstract

A total of 76 premature newborn infants with gestational age of 34 weeks or less were enrolled in a randomized controlled study to determine whether intravenously administrated immunoglobulin (IVIG) is able to prevent nosocomial sepsis. Forty infants were given 0.5 g/kg IVIG on the first day of life and 36 infants with similar gestational age and birth weight were selected as controls and did not receive IVIG. The frequency of proven sepsis, with a positive blood and/or cerebrospinal fluid culture, was significantly lower in infants who received IVIG as compared to controls (42.5vs 80.0%) (p<0.01). The mortality rate attributable to infection was not different in IVIG recipients and in controls (41vs 48%) (p>0.05). The overall mortality rates in the two groups were not different either (35.0vs 44.4%) (p>0.05). The majority of micro-organisms isolated from the blood culture of the patients were gram negative microorganisms (Klebsiella, Enterobacter). IVIG therapy was believed to be effective for prophylaxis of nosocomial infection, but such therapy was not able to reduce overall mortality rate or mortality rate due to systemic infection in prematurely born infants in our intensive care unit where the causative pathogens are usually gram negative microorganisms.

Key words

IVIG Neonatal sepsis Nosocomial infection 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Eriksson M. Neonatal septicemia.Acta Paediatr Scand 1933; 72: 1–8.CrossRefGoogle Scholar
  2. 2.
    Satar M, Atici A, Yilmaz M. Nosocomial infections in the neonatal unit of Cukurova medical faculty.Cukurova Univ Tip Fak Der 1993; 18: 294–298.Google Scholar
  3. 3.
    Satar M, Atici A, Savas Net al. The etiology of neonatal sepsis.Ann Med Sci 1994; 3: 12–15.Google Scholar
  4. 4.
    Bhutta ZA, Naqvi SH, Muzaffar Tet al Neonatal sepsis in Pakistan: presentations and pathogens.Acta Paediatr Scand 1991; 80: 596–601.PubMedCrossRefGoogle Scholar
  5. 5.
    Stabile A, Sopo SM, Romanelli Vet al. Intravenous immunoglobulin for prophylaxis of neonatal sepsis in premature infants.Arch Dis Child 1988; 63: 441–443.PubMedGoogle Scholar
  6. 6.
    Ballow M, Fang F, Good RAet al. Developmental aspects of complement components in the newborn.Clin Exp Immunol 1974; 18: 257–266.PubMedGoogle Scholar
  7. 7.
    Hill HR, Augustine NH, Jaffe HS. Human recombinant interferon gamma enhances neonatal PMN activation and movement and increases free intracellular calcium.J Exp Med 1991; 173: 767–770.PubMedCrossRefGoogle Scholar
  8. 8.
    Haque KN, Zaidi MH, Haque SKet al. Intravenous immunoglobulin for prevention of sepsis in preterm and low birth weight infants.Pediatr Infect Dis 1986; 5: 622–625.PubMedGoogle Scholar
  9. 9.
    Chirico G, Rondini G, Plebani Aet al. Intravenous gammaglobulin therapy for prophylaxis of infection in high-risk neonates.J Pediatr 1987; 110: 437–442.PubMedCrossRefGoogle Scholar
  10. 10.
    Kinney J, Mundorf L, Gleason C. Efficacy and pharmacokinetics of intravenous immune globulin administration to high-risk neonates.Am J Dis Child 1991; 145: 1233–1238.PubMedGoogle Scholar
  11. 11.
    Magny JF, Bremard-Oury C, Brault D. Intravenous immunoglobulin-therapy for prevention of infection in highrisk premature infants: report of a multicenter, double-blind study.Pediatrics 1991; 88: 437–443.PubMedGoogle Scholar
  12. 12.
    Fanaroff AA, Korones SB, Wright LLet al. A controlled trial of intravenous immune globulin to reduce nosocomial infections in very-low-birth-weight infants.N Engl J Med 1994; 330: 1107–1113.PubMedCrossRefGoogle Scholar
  13. 13.
    Farr V, Mitchell RG, Neligan GA. The definition of some external characteristics used in the assessment of gestational age in the newborn infant.Develop Med Clin Neurol 1966; 8: 507–511.Google Scholar
  14. 14.
    Hill HR. Intravenous immunoglobulin use in the neonate: role in prophylaxis and therapy of infection.Pediatr Infect Dis J 1993; 12: 549–559.PubMedCrossRefGoogle Scholar
  15. 15.
    Baker CJ, Melish ME, Hall RTet al. Givner LB and the Multicenter Group for the study of immune globulin in Neonates. Intravenous immune globulin for the prevention of nosocomial infection in low-birth-weight neonates.N Engl J Med 1992; 327: 213–219.PubMedGoogle Scholar
  16. 16.
    Conway SP, Ng PC, Howel Det al. Prophylactic intravenous immunoglobulin in pre-term infants: a controlled trial.Vox Sang 1990; 59: 6–11.PubMedCrossRefGoogle Scholar

Copyright information

© Dr. K C Chaudhuri Foundation 1996

Authors and Affiliations

  • Aytuğg Atici
    • 1
  • Mehmet Satar
    • 1
  • Aysun Karabay
    • 1
  • Mustafa Yilmaz
    • 1
  1. 1.Department of NeonatologyCukurova University Medical FacultyAdanaTurkey

Personalised recommendations